This filing is an initial statement of beneficial ownership of securities filed by Ann Michelle Cunningham, a director at ALTERITY THERAPEUTICS LTD. The report indicates that Ms. Cunningham has no securities owned as of the period of report, April 17, 2026. The filing is made in accordance with SEC regulations for repo...

This filing documents a Power of Attorney granted by Michael A. Panzara to Ilan Katz, Grant Levine, Zach Weiss, Madeline Hunter, and Margaux Bouchet of Dentons US LLP. The attorneys-in-fact are authorized to manage Panzara's EDGAR account, prepare and submit various securities filings with the SEC, including Forms 3, 4...

This filing details changes in beneficial ownership for Immuron Ltd. (IMRN). Ravi Savarirayan, a director, acquired options to purchase 1,000,000 ordinary shares with an exercise price of $0.0789 and 333,333 ordinary shares with an exercise price of $0.1040. These options have various vesting and expiration dates in 20...

This filing reports the initial statement of beneficial ownership for Steven George Lydeamore, Chief Executive Officer of Immuron Ltd. As of March 18, 2026, Mr. Lydeamore directly owns 3,155,047 ordinary shares. The filing also details derivative holdings, including 1,430,000 options with an exercise price of $0.0861 a...

This filing details stock options granted to Jeannette Anne Joughin, a director at Immuron Ltd (IMRN). The options are for ordinary shares, with specific exercise dates and prices. One set of options, totaling 666,666 shares, became exercisable in stages starting December 9, 2024, with a conversion price of $0.0932 USD...

This is a Form 3 filing by Aaron James Laurita, Chief Financial Officer of Immuron Ltd (ticker: IMRN). The filing reports that as of February 9, 2026, Laurita owns no securities in the company. The filing was signed on April 29, 2026, and indicates Laurita's position as CFO but not as a director or 10% owner. The addre...

This Form 3 filing reports the initial statement of beneficial ownership by Jerry Kanellos, Chief Scientific Officer of Immuron Ltd. The filing discloses Kanellos' holdings as of March 18, 2026, including direct ownership of 333,000 ordinary shares. Additionally, the filing reports two sets of performance rights: 179,6...

This filing is an initial report of beneficial ownership for Ji Ping, a director at Adlai Nortye Ltd. (ANL). The report, designated as Form 3, indicates that Ji Ping acquired no new securities and currently holds no direct or indirect beneficial ownership of the company's securities as of March 18, 2026. The reporting ...

This filing details stock options granted to Jeannette Anne Joughin, a director at Immuron Ltd (IMRN). The options are for ordinary shares, with specific exercise dates and prices. One set of options, totaling 666,666 shares, became exercisable in stages starting December 9, 2024, with a conversion price of $0.0932 USD...

This Form 3 filing reports the initial statement of beneficial ownership by Jerry Kanellos, Chief Scientific Officer of Immuron Ltd. The filing discloses Kanellos' holdings as of March 18, 2026, including direct ownership of 333,000 ordinary shares. Additionally, the filing reports two sets of performance rights: 179,6...